Connect with us
[the_ad id="89560"]

Health

Horrific and Deadly Effects of Antidepressants

Published

11 minute read

 The Vigilant Fox

Once you see what else these drugs are doing, you’ll never look at depression “treatment” the same way again.

The following information is based on a report originally published by A Midwestern Doctor. Key details have been streamlined and editorialized for clarity and impact. Read the original report here.

Did you know that SSRI antidepressants INCREASE suicidal thoughts by 255%?

A clinical trial on healthy volunteers found that 2 out of 20 became suicidal after taking Zoloft.

One was literally on her way to kill herself when a timely phone call saved her life.

But it’s not just suicidal thoughts that make antidepressants dangerous.

And once you see what else these drugs are doing, you’ll never look at depression “treatment” the same way again.

Selective serotonin reuptake inhibitors—or SSRIs—are one of the most harmful medicines prescribed today.

And that’s saying a lot because the market is FULL of harmful medicines.

What’s so bad about these antidepressants?

First of all, their use is widespread and frequently unjustifiable.

They promise to be a magical solution to depression and anxiety, but it’s quite the opposite.

In fact, they can cause side effects far worse than what they claim to treat.

SSRIs don’t just dull your emotions, and they don’t alter your brain chemistry for the better.

They literally reprogram your brain.

Between 40% and 60% of users report emotional numbness. Not just negative emotions—all emotions.

Joy, pain, motivation—all of it completely flatlined.

Some describe it as “life without color” or a “zombie-like” existence.

Sure, maybe you don’t feel depressed anymore. But you don’t feel anything at all.

That sounds… terrible.

Depression can be serious, but should we accept emotionless zombies as the alternative?

If you want to dig even deeper into the dark side of antidepressants and why they’re so harmful, check out @Midwesterndoc’s comprehensive report on the subject. And be sure to share this with anyone you know who may be considering starting an SSRI.

And it’s not just becoming an emotionless zombie you have to worry about. The emotional shutdown can lead to something that is much worse than depression and anxiety.

Psychotic violence.

I don’t mean just a little anger here and there.

SSRIs are causing people to commit suicide—and yes, even horrific mass shootings.

And guess what? The FDA knew about it.

Prozac triggers hallucinations, mania, and violence, and the FDA has known all along.

Even animals become aggressive on SSRIs.

But instead of going back to the drawing board, the FDA approved it anyway.

After nine years on the market, 39,000 people reported major psychiatric events. And those are only the people who reported it…

Really makes you question FDA approval, doesn’t it?

Did you know most of the mass shooters we hear about in the news were often on SSRIs?

It’s true.

And the media even reported on it. But then, they stopped.

That’s weird.

So why are we “not allowed” to talk about SSRIs and violence anymore?

It’s pretty simple.

It would blow the lid off one of the most dangerous pharmaceutical cover-ups in modern history.

It would expose the truth that Big Pharma knowingly released drugs that could make people snap and kill other people.

And they just kept selling them anyway.

But the psychotic violence caused by SSRIs is only the tip of the iceberg.

Obviously, not everyone taking these drugs becomes a mass shooter. But that doesn’t mean the other side effects are any less terrible for those who experience them.

SSRIs truly warp your mind, body, and emotions. And sometimes it is irreversible.

The numbers are truly chilling:
→ A 255% increase in suicidal thoughts
→ 30% of SSRI users develop Bipolar disorder
→ 59% suffer long-term sexual dysfunction

With many saying their libido never came back even after stopping the drug.

The science is clear. The harm caused by SSRIs greatly outweighs any benefits they provide.

Talk about depressing…

A 2020 study involving 20 healthy volunteers with zero history of depression or other mental illnesses had shocking results.

They were each given Zoloft.

TWO of them BECAME suicidal.

One of them was even on her way to kill herself when a divinely timed phone call interrupted her plans.

These two study participants were still affected several months later. They were actually questioning the stability of their personalities.

This doesn’t sound like a magic solution. This sounds like torture.

Speaking of stopping SSRIs—good luck!

They are highly addictive.

And it’s not just physical addiction. It’s neurological.

And because of what they do to the brain, it can take years to step down the dose and wean off of them. Years!

Withdrawal symptoms include things like:
– Brain zaps
– Panic attacks
– Suicidal spirals
– Derealization

And these symptoms can last weeks, months, or even years.

It’s not uncommon to fail and continue taking them because the withdrawal is just that bad.

A 2022 review found that 56% of users who tried to stop SSRIs experience withdrawal symptoms, and 46% describe it as severe.

Psychiatrists mislabel it as a “relapse” and prescribe even more drugs.

The system is set up to trap you. There’s no exit.

And the most vulnerable groups?

Pregnant women and children.

Despite strong evidence linking SSRIs to birth defects, premature birth, and newborn deaththe FDA still endorses their use during pregnancy.

One study showed a six times higher risk of pulmonary hypertension in newborns.

Another study showed that SSRI babies lost height and weight in just 19 weeks.

This isn’t good.

SSRIs are being pushed on everyone. Especially vulnerable people like foster kids, parolees, prisoners, and elderly nursing home residents.

And in many of these cases, there is no real ability for them to say no.

That’s not mental health care. That’s drugging people.

The industry tells us SSRIs are “fixing a serotonin imbalance.”

But that’s a lie.

There’s no solid evidence that depression is caused by low serotonin.

So what’s the real mechanism at play here?

SSRIs alter brain wiring. And obviously not always in good ways.

SSRI users describe feeling like their “personality changed” after starting the drug.

The reports are endless and absolutely chilling.

Some were left numb for years. Others became aggressive, impulsive, or dissociated from reality.

Many say they don’t recognize who they became after taking SSRIs.

Excuse me… what?!

And of course, patients and their families are rarely warned about these effects.

Most say they were never told about the risks. There was no informed consent.

How can you not inform depressed people that their medication might make them suicidal? How is it even possible that we can be asking that question?

They experienced these things and talked to their doctors.

They were gaslit every step of the way.

If you or someone you love is taking SSRIs or is considering taking them, I urge you to read the full report from A Midwestern Doctor

How many more people have to suffer before this ends?

How many more people who reach out to their doctor because something is off and they’re looking for help are going to be hurt, sometimes permanently?

It’s time to expose the cover-up and end Big Pharma’s abuse and gaslighting once and for all.

RFK Jr. is right—this could finally be the turning point.

For 40 years, this tragedy was hidden behind slick ads and corrupted science.

But now it’s in the light and MAHA is ready to fight.

If you know anyone considering starting an SSRI, be sure to forward them this information. Because if you wait until after, it might be too late.

Share

Thanks for reading!

This information was based on a report originally published by A Midwestern Doctor. Key details were streamlined and editorialized for clarity and impact. 

Read the original report here.

Mental Health

Suspect who killed 11 in Vancouver festival attack ID’d

Published on

MXM logo  MxM News

Quick Hit:

Authorities have identified the driver responsible for the devastating attack at Vancouver’s Lapu Lapu Day festival that killed at least 11 and injured dozens more. The suspect, Kai-Ji Adam Lo, 30, had a well-documented history of mental illness, and his family sought help just hours before the tragic event.

Key Details:

  • Kai-Ji Adam Lo, 30, was identified as the driver who plowed into a crowd, killing 11 and injuring dozens more.
  • Lo’s family sought psychiatric help for him hours before the attack; he was already known to law enforcement.
  • Police believe the attack was not terror-related, citing Lo’s extensive mental health struggles.

Diving Deeper:

The city of Vancouver is grappling with unspeakable tragedy following the deadly assault that unfolded during the Lapu Lapu Day festival, a vibrant celebration honoring the Filipino community. Authorities have identified the man behind the wheel as 30-year-old Kai-Ji Adam Lo, who was apprehended at the scene Saturday night.

Lo, whose troubled history with mental illness was well known to local authorities and mental health professionals, faces eight counts of second-degree murder, with additional charges expected as the investigation continues. According to reports, Lo’s family had reached out to a hospital psychiatric ward just hours before the incident, desperately seeking help for him amid his escalating paranoia and delusions. It remains unclear whether any intervention was made in response to the family’s call.

Vancouver Police Chief Steve Rai confirmed that Lo had no interactions with law enforcement immediately prior to the event, but acknowledged that the city is reeling from its “darkest day.” Investigators emphasized that, because of Lo’s mental state, they do not believe the attack was terror-related.

Adding to the complex portrait of the suspect, Lo was mourning profound personal loss. His brother, Alexander Lo, was murdered in January 2024. Following the death, Lo had penned heartbreaking posts online, sharing how his brother’s death and his mother’s subsequent suicide attempt shattered their family.

Tragically, among the 11 killed during Saturday’s carnage was a 5-year-old child. Dozens more were wounded when Lo drove his SUV into the densely packed crowd gathered for the festivities. Lo has since appeared in court and will remain in custody as prosecutors prepare to bring additional charges.

The horror that unfolded in Vancouver serves as a stark reminder of the broader systemic failures surrounding mental health interventions. While Canadian authorities attempt to grapple with the aftermath, this tragedy sadly echoes similar stories in other nations where warnings about individuals in crisis have gone unheeded—with catastrophic results.

Continue Reading

Addictions

Four new studies show link between heavy cannabis use, serious health risks

Published on

Cannabis products purchased in Ontario and B.C., including gummies, pre-rolled joints, chocolates and dried flower; April 11, 2025. [Photo credit: Alexandra Keeler]

By Alexandra Keeler

New Canadian research shows a connection between heavy cannabis use and dementia, heart attacks, schizophrenia and even death

Six months ago, doctors in Boston began noticing a concerning trend: young patients were showing up in emergency rooms with atypical symptoms and being diagnosed with heart attacks.

“The link between them was that they were heavy cannabis users,” Dr. Ahmed Mahmoud, a cardiovascular researcher and physician in Boston, told Canadian Affairs in an interview.

These frontline observations mirror emerging evidence by Canadian researchers showing heavy cannabis use is associated with significant adverse health impacts, including heart attacks, schizophrenia and dementia.

Sources warn public health measures are not keeping pace with rapid changes to cannabis products as the market is commercialized.

“The irony of this moment is that society’s risk perception of cannabis is at an all-time low, at the exact moment that the substance is probably having increasingly negative health impacts,” said Dr. Daniel Myran, a physician and Canada Research Chair at the University of Ottawa. Myran was lead researcher on three new Canadian studies on cannabis’ negative health impacts.

Legalization

Canada was the first G7 country to create a commercial cannabis market when it legalized the production and sale of cannabis in 2018.

The drug is now widely used in Canada.

In the 2024 Canadian Cannabis Survey, an annual government survey of cannabis trends, 26 per cent of respondents said they used cannabis for non-medical purposes in the past year, up from 22 per cent in 2018. Among youth, that number was 41 per cent.

Health Canada’s website warns that cannabis use can lower blood pressure and raise heart rates, which can increase the risk of a heart attack. But the warnings on cannabis product labels vary. Some mention risks of anxiety or effects on memory and concentration, but make no mention of cardiovascular risks.

The annual cannabis survey also shows a significant percentage of Canadians remain unaware of cannabis’ health risks.

In the survey, only 70 per cent of respondents said they had enough reliable information to make informed decisions about cannabis use. And 50 per cent of respondents said they had not seen any education campaigns or public health messages about cannabis.

At the same time, researchers are finding mounting evidence that cannabis use is associated with health risks.

A 2023 study by researchers at the University of Calgary, the University of Alberta and Alberta Health Services found that adults with cannabis use disorder faced a 60 per cent higher risk of experiencing adverse cardiovascular events — including heart attacks. Cannabis use disorder is marked by the inability to stop using cannabis despite negative consequences, such as work, social, legal or health issues.

Between February and April of this year, three other Canadian studies linked frequent cannabis use to elevated risks of developing schizophrenia, dementia and mortality. These studies were primarily conducted by researchers at the Ottawa Hospital Research Institute and ICES uOttawa (formerly the Institute for Clinical Evaluative Sciences).

“These results suggest that individuals who require hospital-based care for a [cannabis use disorder] may be at increased risk of premature death,” said the study linking cannabis-related hospital visits with increased mortality rates.

The three 2024 studies all examined the impacts of severe cannabis use, suggesting more moderate users may face lower risks. The researchers also cautioned that their research shows a correlation between heavy cannabis use and adverse health effects, but does not establish causality.

 

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

 

Budtenders

Health experts say they are troubled by the widespread perception that cannabis is entirely benign.

“It has some benefits, it has some side effects,” said Mahmoud, the Boston cardiovascular researcher. “We need to raise awareness about the side effects as well as the benefits.”

Some also expressed concern that the commercialization of cannabis products in Canada has created a race to produce products with elevated levels of THC, the main psychoactive compound that produces a “high.”

THC levels have more than doubled since legalization, yet even products with high THC levels are marketed as harmless.

“The products that are on the market are evolving in ways that are concerning,” Myran said. “Higher THC products are associated with considerably more risk.”

Myran views cannabis decriminalization as a public health success, because it keeps young people out of the criminal justice system and reduces inequities faced by Indigenous and racialized groups.

“[But] I do not think that you need to create a commercial cannabis market or industry in order to achieve those public health benefits,” he said.

Since decriminalization, the provinces have taken different approaches to regulating cannabis. But even in provinces where governments control cannabis distribution, such as New Brunswick and Nova Scotia, products with high THC levels dominate retail shelves and online storefronts.

In Myran’s view, federal and provincial governments should instead be focused on curbing harmful use patterns, rather than promoting cannabis sales.

Ian Culbert, executive director of the Canadian Public Health Association, thinks governments’ financial interest in the cannabis industry creates a conflict of interest.

“[As with] all regulated substances, governments are addicted to the revenue they create,” he said. “But they also have a responsibility to safeguard the well-being of citizens.”

Culbert believes cannabis retailers should be required to educate customers about health risks — just as bartenders are required to undergo Smart Serve training and lottery corporations are required to mitigate risks of gambling addiction.

“Give ‘budtenders’ the training around potential health risks,” he said.

“While cannabis may not be the cause of some of these negative health events … it is the intersection at which an intervention can take place through the transaction of sales. So is there something we can do there that can change the trajectory of a person’s life?”


This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.

Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.

Continue Reading

Trending

X